New synthetic surfactant - How and when?

Biology of the Neonate

Volumn 89, Issue 4, 2006, Pages 336-339

  Curstedt, Tore ^a   Johansson, Jan ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Lung disease; Pulmonary surfactant; Respiratory distress syndrome; Surfactant protein B; Surfactant protein C; Synthetic surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; KL 4 PEPTIDE; LUCINACTANT; LUSUPULTIDE; PHOSPHOLIPID; PORACTANT; RECOMBINANT PROTEIN; RECOMBINANT SURFACTANT PROTEIN B; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN C33; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG MIXTURE; HUMAN; LIPID TRANSPORT; LUNG ALVEOLUS; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; RESPIRATORY DISTRESS SYNDROME;

ANIMALS; HUMANS; PEPTIDES; PULMONARY SURFACTANTS; SURFACE-ACTIVE AGENTS;

ANIMALIA;

EID: 33745068925     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092871     Document Type: Conference Paper

References (33)

1. Kattwinkel J: Synthetic surfactants: the search goes on. Pediatrics 2005;115:1075-1076.
2. Berggren P, Curstedt T, Grossmann G, Nilsson R, Robertson B: Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids. Exp Lung Res 1985;8:29-51.
3. Johansson J, Curstedt T: Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 1997;244:675-693.
4. Curstedt T, Johansson J: New synthetic surfactants - basic science. Biol Neonate 2005;87:332-337.
5. McLean LR, Lewis JE, Krstenansky JL, Hagaman KA, Cope AS, Olsen KF, Matthews ER, Uhrhammer DC: An amphipathic α-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant. Am Rev Respir Dis 1993;147:462-465.
6. Seurynck SL, Patch JA, Barron AE: Simple, helical peptoid analogues of lung surfactant protein B. Chem Biol 2005;12:77-88.
7. Wu CW, Seurynck SL, Lee, KYC, Barron AE: Helical peptoid mimics of lung surfactant protein C. Chem Biol 2003;10:1057-1063.
8. Cochrane CG, Revak SD: Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991;254:566-568.
9. Merritt TA: Concerning the article by T. Curstedt and J. Johansson: New synthetic surfactants - basic science. Biol Neonate 2006;89:257-258.
10. Curstedt T, Johansson J: Letter to the editor - reply. Biol Neonate 2006;89:258-259.
11. Gupta M, Hernández-Juviel JM, Waring AJ, Bruni R, Walther FJ: Comparison of functional efficacy of surfactant protein B analogues in lavaged rats. Eur Respir J 2000;16:1129-1133.
12. 1-25. Biophys J 2000;79:377-384.
13. Waring AJ, Walther FJ, Gordon LM, Hernandez-Juviel JM, Hong T, Sherman MA, Alonso C, Alig T, Braun A, Bacon D, Zasadzinski JA: The role of charged amphipathic helices in the structure and function of surfactant protein B. J Peptide Res 2005;66:364-374.
14. Hawgood S, Ogawa A, Yukitake K, Schlueter M, Brown C, White T, Buckley D, Lesikar D, Benson B: Lung function in premature rabbits treated with recombinant human surfactant protein-C. Am J Respir Crit Care Med 1996;154:484-490.
15. Davis AJ, Jobe AH, Hafner D, Ikegami M: Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med 1998;157:553-559.
16. Häfner D, Germann PG, Hauschke D: Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. Br J Pharmacol 1998;124:1083-1090.
17. Takei T, Hashimoto Y, Aiba T, Sakai K, Fujiwara T: The surface properties of chemically synthesized peptides analogous to human pulmonary surfactant protein SP-C. Biol Pharm Bull 1996;19:1247-1253.
18. Takei T, Hashimoto Y, Otsubo E, Sakai K, Ohkawa H: Characterization of poly-leucine substituted analogues of the human surfactant protein SP-C. Biol Pharm Bull 1996;19:1550-1555.
19. Nilsson G, Gustafsson M, Vandenbussche G, Veldhuizen E, Griffiths WJ, Sjövall J, Haagsman HP, Ruysschaert JM, Robertson B, Curstedt T, Johansson J: Synthetic peptide-containing surfactants. Evaluation of transmembrane versus amphipathic helices and SP-C poly-valyl to poly-leucyl substitution. Eur J Biochem 1998;255:116-124.
20. Johansson J, Some M, Linderholm BM, Almlén A, Curstedt T, Robertson B: A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits. J Appl Physiol 2003;95:2055-2063.
21. 4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome. Pediatr Res 1995;38:211-217.
22. Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A: Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr Res 1996;39:715-724.
23. Gastiasoro-Cuesta E, Alvarez-Diaz FJ, Rey-Santano C, Amaiz-Renedo A, Loureiro-Gonzalez B, Valls-i-Soler A: Acute and sustained effects of lucinactant versus poractant-α on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome. Pediatrics 2006;117:295-303.
24. Michna J, Jobe AH, Ikegami M: Positive end-expiratory pressure preserves surfactant function in preterm lambs. Am J Respir Crit Care Med 1999;160:634-639.
25. Balaraman V, Meister J, Ku TL, Sood SL, Tam E, Killeen J, Uyehara CFT, Egan E, Easa D: Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Am J Respir Crit Care Med 1998;158:12-17.
26. Walther FJ, Hernández-Juviel JM, Gordon LM, Waring AJ, Stenger P, Zasadzinski JA: Comparison of three lipid formulations for synthetic surfactant with a surfactant protein B analog. Exp Lung Res 2005;31:563-579.
27. Spragg RG, Smith RM, Harris K, Lewis J, Hafner D, Germann P: Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. J Appl Physiol 2000;88:674-681.
28. Spragg RG, Lewis JF, Wurst W, Häfner D, Baughman RP, Wewers, MD, Marsh JJ: Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 2003;167:1562-1566.
29. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Häfner D, Taut FJH, Seeger W: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:884-892.
30. Moya FR, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A, Kornacka MK, Merritt TA, Segal R, Schaber CJ, Tsai H, Massaro J, d'Agostino R for the International Surfaxin Collaborative Study Group: A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 2005;115:1018-1029.
31. Sinha SK, Lacaze-Masmonteil T, Valls-i-Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R for the Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group: A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 2005;115:1030-1038.
32. 4 surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med 1999;160:1188-1195.
33. Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF, Sekar KC, Bernstein G, Keszler M, Visser VE, Merritt TA, Mannino FL, Mastrioianni L, Marcy B, Revak SD, Tsai H, Cochrane CG: A multicenter, randomized, controlled trial comparing surfaxin (lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002;109:1081-1087.